UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 21, 2007
|
AGILENT TECHNOLOGIES, INC. |
|
(Exact name of registrant as specified in its charter) |
|
Delaware |
|
001-15405 |
|
77-0518772 |
|
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
|
of incorporation) |
|
File Number) |
|
Identification No.) |
|
|
|
|
|
|
|
5301 Stevens Creek Boulevard, Santa Clara, CA |
|
95051 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
Registrant’s telephone number, including area code (408) 553-2424
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 23, 2007, Agilent Technologies, Inc. (the “Company”) announced that, effective October 31, 2007, Christopher van Ingen will retire and step down as Senior Vice President of the Company and President of the Company’s Bio-Analytical Measurement business.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following is filed as an exhibit to this report:
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press release announcing management change in
Bio-Analytical Measurement |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
AGILENT TECHNOLOGIES, INC. |
||
|
|
|
|
|
|
|
|
|
By: |
/s/ Marie Oh Huber |
|
|
|
Name: |
Marie Oh Huber |
|
|
Title: |
Vice President, Deputy General Counsel and |
|
|
|
Assistant Secretary |
|
|
|
|
|
|
|
|
|
Date: August 23, 2007 |
|
|
3
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press release announcing management change in
Bio-Analytical Measurement |
4